T1	Participants 431 451	Thirty-five patients
T2	Participants 473 475	18
T3	Participants 522 524	17
T4	Participants 852 865	placebo group
T5	Participants 623 631	patients
T6	Participants 639 653	ketamine group
T7	Participants 1055 1069	ketamine group
T8	Participants 1404 1418	patient group.
